Den europeiske union -
norsk -
EMA (European Medicines Agency)
nexpovio
stemline therapeutics b.v. - selinexor - multippelt myelom - antineoplastiske midler - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
Norge -
norsk -
Statens legemiddelverk
eplerenon accord 25 mg
accord healthcare b.v. - eplerenon - tablett, filmdrasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
eplerenon accord 50 mg
accord healthcare b.v. - eplerenon - tablett, filmdrasjert - 50 mg
Norge -
norsk -
Statens legemiddelverk
eplerenon medical valley 25 mg
medical valley invest ab - eplerenon - tablett, filmdrasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
eplerenon medical valley 50 mg
medical valley invest ab - eplerenon - tablett, filmdrasjert - 50 mg
Norge -
norsk -
Statens legemiddelverk
inspra 25 mg
upjohn eesv - eplerenon - tablett, filmdrasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
inspra 50 mg
upjohn eesv - eplerenon - tablett, filmdrasjert - 50 mg
Norge -
norsk -
Statens legemiddelverk
eplerenon krka 25 mg
krka, d.d. novo mesto - eplerenon - tablett, filmdrasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
eplerenon krka 50 mg
krka, d.d. novo mesto - eplerenon - tablett, filmdrasjert - 50 mg